Singe Nucleotide Polymorphisms in Osteosarcoma: Pathogenic Effect and Prognostic Significance Publisher Pubmed



Asnafi AA¹ ; Behzad MM¹ ; Ghanavat M² ; Shahjahani M¹ ; Saki N¹ Show Affiliations
Source: Experimental and Molecular Pathology Published:2019

Abstract

Purpose: Osteosarcoma (OS) is a common malignant bone tumor in children and adolescents. Pathogenesis and prognosis of OS can be associated with several environmental and genetic factors. Single nucleotide polymorphisms (SNPs) are crucial genetic changes that can be involved in clinical and therapeutic outcomes of OS. The aim of this review is to present a synopsis of the role of SNPs in pathogenesis and prognosis of OS tumor cells as well as their potential as therapeutic targets to improve the outcomes of patients. Method: The content used in this paper has been obtained by an electronic databases search of English language (1998–2018) articles using the terms “Single nucleotide polymorphisms” “Osteosarcoma” “Pathogenesis” “Prognosis” and “Clinical Outcomes”. Discussion: SNPs can affect a number of biological processes such as proliferation, apoptosis, adhesion, invasion, and drug resistance of OS tumor cells, playing a key role in pathogenesis, prognosis, and clinical outcomes after chemotherapy in this disease. Conclusion: Considering the importance of SNPs in OS pathophysiology, these genetic changes may be used as potential pathogenic and prognostic biomarkers for OS. It is hoped that targeting these changes using new therapeutic approaches leads to the effective treatment of this debilitating tumor. However, better understanding of OS biology and further clinical trials are needed to achieve this goal. © 2018 Elsevier Inc.